Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Arcutis Biotherapeutics Inc?

Accepted Answer

Según el último estado financiero (Form-10K), Arcutis Biotherapeutics Inc tiene un total de activos de $348, una ganancia neta loss de $-140

Question 2

¿Cuáles son los ratios financieros clave para ARQT?

Accepted Answer

El ratio corriente de Arcutis Biotherapeutics Inc es 1.82, el margen neto es -71.42, las ventas por acción son $1.62.

Question 3

¿Cómo se desglosan los ingresos de Arcutis Biotherapeutics Inc por segmento o geografía?

Accepted Answer

Arcutis Biotherapeutics Inc largest revenue segment is Dermatological Treatments, at a revenue of 196,542,000 in the most earnings release.For geography, United States and Canada is the primary market for Arcutis Biotherapeutics Inc, at a revenue of 196,542,000.

Question 4

¿Es rentable Arcutis Biotherapeutics Inc?

Accepted Answer

no, según los últimos estados financieros, Arcutis Biotherapeutics Inc tiene una ganancia neta loss de $-140

Question 5

¿Tiene Arcutis Biotherapeutics Inc alguna deuda?

Accepted Answer

yes, Arcutis Biotherapeutics Inc tiene una deuda de 191

Question 6

¿Cuántas acciones en circulación tiene Arcutis Biotherapeutics Inc?

Accepted Answer

Arcutis Biotherapeutics Inc tiene un total de acciones en circulación de 117.84

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	317	196	59	3	0	0
Revenue Growth (YoY)	130%	231.99%	1,867%	--	--	--
Cost of Revenue	31	19	4	0	--	--
Gross Profit	286	177	54	2	--	--
Selling, General & Admin	253	229	185	122	60	21
Research & Development	71	76	110	182	145	115
Operating Expenses	324	305	295	304	206	136
Other Non Operating Income (Expenses)	9	16	11	5	0	0
Pretax Income	-43	-139	-259	-311	-206	-135
Income Tax Expense	1	0	3	--	--	--
Net Income	-44	-140	-262	-311	-206	-135
Net Income Growth	-77%	-47%	-16%	51%	53%	221%
Shares Outstanding (Diluted)	132.88	120.95	69.3	55.03	49.41	35.67
Shares Change (YoY)	7%	75%	26%	11%	39%	-3%
EPS (Diluted)	-0.33	-1.15	-3.78	-5.66	-4.18	-3.8
EPS Growth	-79%	-69%	-33%	35%	10%	229.99%
Free Cash Flow	-48	-117	-247	-281	-175	-113
Free Cash Flow Per Share	-0.36	-0.96	-3.56	-5.1	-3.54	-3.16
Gross Margin	90.22%	90.3%	91.52%	66.66%	--	--
Operating Margin	-11.98%	-65.3%	-408.47%	-10,033.33%	0%	0%
Profit Margin	-13.88%	-71.42%	-444.06%	-10,366.66%	0%	0%
Free Cash Flow Margin	-15.14%	-59.69%	-418.64%	-9,366.66%	0%	0%
EBITDA	-34	-126	-240	-301	-206	-136
EBITDA Margin	-10.72%	-64.28%	-406.77%	-10,033.33%	0%	0%
D&A For EBITDA	4	2	1	0	0	0
EBIT	-38	-128	-241	-301	-206	-136
EBIT Margin	-11.98%	-65.3%	-408.47%	-10,033.33%	0%	0%
Effective Tax Rate	-2.32%	0%	-1.15%	--	--	--

Arcutis Biotherapeutics Inc (ARQT) Price

ARQT Stock Price Chart

ARQT Income

Follow-Up Questions